» Articles » PMID: 39061209

Changes in Time to Initial Physician Contact and Cancer Stage Distribution During the COVID-19 Pandemic in Patients with Head and Neck Squamous Cell Carcinoma at a Large Hungarian Cancer Center

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Jul 27
PMID 39061209
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of our study was to compare the characteristics and time to initial physician contact in patients with head and neck squamous cell carcinoma (HNSCC) before and during the COVID-19 pandemic at a large Hungarian cancer center. This was a retrospective study of patients 18 years or older presenting at the regional cancer center of Pécs Clinical Center with HNSCC between 1 January 2017, and 15 March 2020 (the pre-COVID-19 period) and between 16 March 2020, and 13 May 2021 (the COVID-19 period). Demographic and clinical data were collected, and the time between initial symptom onset and initial physician contact (TTP) was determined. Descriptive and exploratory statistical analyses were performed. On average, the number of patients diagnosed with HNSCC per month during the pandemic decreased by 12.4% compared with the pre-COVID-19 period. There was a significant increase in stage I and stage II cancers (from 15.9% to 20.3% and from 12.2% to 13.8%, respectively; p < 0.001); a decrease in stage III and IVa,c cancers; and a significant increase in stage IVb cancers (from 6% to 19.9%; p < 0.001) during the pandemic. The median TTP increased during the pandemic from 43 to 61 days (p = 0.032). To our knowledge, this is the first study investigating the effect of COVID-19 on patients with HNSCC in the Central-Eastern European region. We found a bidirectional shift in cancer stages and increased TTP during the pandemic. Our findings highlight the necessity for more nuanced analyses of the effects of COVID-19.

Citing Articles

Shorter Time to Biopsy of Patients with Head and Neck Squamous Cell Carcinoma During the COVID-19 Pandemic in Hungary.

Szabo E, Kopjar E, Rumi L, Bellyei S, Zemplenyi A, Matyus E Cancers (Basel). 2025; 17(3).

PMID: 39941734 PMC: 11815749. DOI: 10.3390/cancers17030360.

References
1.
Carlsen A, Eriksen J, Godballe C, Johansen J, Sorensen J, Bjorndal K . Impact of age, comorbidity, and WHO performance status on delay of treatment in patients undergoing fast-track work-up for head and neck cancer. J Geriatr Oncol. 2018; 10(2):259-264. DOI: 10.1016/j.jgo.2018.06.003. View

2.
Carre J, Herzog B, Reil D, Schneider C, Pfluger M, Lobel M . [Impact of the COVID-19 pandemic on the diagnosis and treatment of patients with head and neck cancer in Brandenburg and Berlin]. HNO. 2023; 72(2):90-101. DOI: 10.1007/s00106-023-01396-6. View

3.
Maehle P, Hajdarevic S, Haland E, Aarhus R, Smeland S, Mork B . Exploring the triggering process of a cancer care reform in three Scandinavian countries. Int J Health Plann Manage. 2021; 36(6):2231-2247. DOI: 10.1002/hpm.3278. View

4.
Nishimura N, Aoki K, Koyama S, Nishio M, Otsuka T, Miyazaki M . The impact of COVID-19 pandemic on head and neck cancer diagnosis and treatment. J Dent Sci. 2024; 19(3):1620-1627. PMC: 11259616. DOI: 10.1016/j.jds.2023.12.005. View

5.
Solberg M, Berg G, Andreassen H . Lost in the loop - a qualitative study on patient experiences of care in standardized cancer patient pathways. BMC Health Serv Res. 2023; 23(1):1371. PMC: 10702039. DOI: 10.1186/s12913-023-10364-3. View